Home » Topics » Regulatory » Patents

Patents
RSS

Chinese researchers report CDK/cyclin inhibitors for cancer

Nov. 11, 2016

Jiangsu Hansoh Pharmaceutical patents FXR agonists

Nov. 11, 2016

Lead Discovery Center and Qurient present TAM receptor kinases and/or MET inhibitors

Nov. 10, 2016

Kainos Medicine develops Brd inhibitors

Nov. 10, 2016

Takeda Pharmaceutical describes orexin receptor antagonists

Nov. 10, 2016

ViiV Healthcare UK discloses antiviral agents

Nov. 10, 2016

Sumitomo Dainippon Pharma patents dopamine D4 receptor agonists

Nov. 10, 2016

Shionogi presents P2X7 antagonists

Nov. 9, 2016

Takeda Pharmaceutical develops SPT inhibitors

Nov. 9, 2016

Araxes Pharma describes mutant K-RAS, H-RAS or N-RAS inhibitors

Nov. 9, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...